Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017
Treatment of Peripheral Neuropathies
JNNP 48:1193-1207, Hallett,M.,et al, 1985
Neurological Syndromes of SLE
Neurol l4:317, Fulton,W.,et al, 1964
Powassan Virus-A New Reemerging Tick-Borne Disease
Front Public Health 5:342, Fatmi,S.S., et al, 2017
Treatment of Brain Metastases
J Clin Oncol 33:3475-3484, Lin, X. & DeAngelis, L.M., 2015
Lamotrigine and Aseptic Meningitis
Neurol 78:921-927, Simms,K.M.,et al, 2012
Lamotrigine: An Unusual Etiology for Aseptic Meningitis
Neurologist 16:35-36, Lam,G.,et al, 2010
Intracerebral Haemorrhage
Lancet 373:1632-1644, Qureshi,A.I.,et al, 2009
Sexual Function in Men and Women With Neurological Disorders
Lancet 369:512-525, Rees,P.M.,et al, 2007
Clinical Update:Diagnosis and Treatment of Essential Tremor
Lancet 369:1152-1154, Benito-Leon,J&Louis,E.D., 2007
Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
JAMA 293:557-564,615, Chang,S.M.,et al, 2005
Brain Metastases
The Neurologist 10:31-46, Klos,K.J.&O'Neill,B.P., 2004
The United Kingdom Infantile Spasms Study Comparing Vigabatrin with Prednisolone or Tetracosactide at 14 Days: A Multicentre, Randomised Controlled Trial
Lancet 364:1773-1778, Lux,A.L.,et al, 2004
Trigeminal Neuralgia and Glossopharyngeal Neuralgia
Neurol Clin N Am 22:185-206, Rozen,T.D., 2004
Antivonvulsants for Creutzfeldt-Jakob Disease?
Lancet 361:224, Fioel,A.,et al, 2003
Neurotoxicity Following Addition of Intravenous Valproate to Lamotrigine Therapy
Neurol 60:1991-1992, Burneo,J.G.,et al, 2003
Recent Advnaces in the Treatment of Epilepsy
Arch Neurol 60:929-935, Nguyen,D.K. &Spencer,S.S., 2003
Sensorineural Hearing Loss: A Reversible Effect of Vigabatrin
Neurol 61:1020-1021, Papdeas,E.,et al, 2003
Evolving Treatment Strategies for Epilepsy
JAMA 287:2917-2920, Diaz-Arrastia,R.,et al, 2002
Vagus Nerve Stimulation and Drug Reduction
Neurol 56:561-563, Tatum,W.O.,et al, 2001
Osteoporosis in Neurological Disorders
JNNP 68:543-549, Lloyd,M.E.,et al, 2000
Management of Epilepsy in Adolescents and Adults
Lancet 356:323-329, Brodie,M.J. & French,J.A., 2000
Visual Impairment in Children with Epilepsy Treated with Vigabatrin
Ann Neurol 48:60-64, Gross-Tsur,V. et al, 2000
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999
Visual Field Defects Associated with Vigabatrin Therapy
JNNP 67:716-722, Lawden,M.C.,et al, 1999
Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997
Treatment of Trigeminal Neuralgia (Editorial)
NEJM 334:1125-1126, Fields,H.L., 1996
Postherpetic Neuralgia-Pathogenesis, Treatment and Prevention
NEJM 335:32-42, Kost,R.G.&Straus,S.E., 1996
Neuropathic Pain of Peripheral Origin:Advances in Pharmacologic Treatment
Neurol 45 (suppl 8) :s17-s25995., Galer,B.S., 1995
Management of Injuries Due to Chemical Weapons
BMJ 302:129-130, Murray,V.S.G.&Volans,G.N., 1991
Suppression of Carbamazepine-Induced Rash with Prednisone
Neurol 41:144-145, Murphy,J.M.,et al, 1991
The Characteristics and Mechanisms of Visual Disturbance Associated with Anticonvulsant Therapy
Neurol 40:791-796, Remler,B.F.,et al, 1990
Stevens-Johnson Syndrome in a Patient Receiving Cranial Irradiation & Carbamazepine
Neurol 40:1144-1145, Hoag-Xuan,K.,et al, 1990
Sensorineural Hearing Loss:A Reversible Effect of Valproic Acid
Neurol 40:1896-1898, Armon,C.,et al, 1990
Adverse Drug Effects on Neuromuscular Transmission
Semin Neurol 10:89-102, Howard,J.F., 1990